Optimizing bexarotene therapy for cutaneous T-cell lymphoma - Reply

被引：0
|
作者：
Duvic, M [1 ]
机构：
[1] MD Anderson Canc Ctr, Dept Dermatol, Houston, TX USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 51卷 / 03期
关键词：
D O I：
10.1016/j.jaad.2003.04.007
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：482 / 483
页数：2
相关论文
共 50 条
  • [21] Oral bexarotene for post-transplant cutaneous T-cell lymphoma
    Lewis, Daniel J.
    Huang, Simo
    Duvic, Madeleine
    DERMATOLOGIC THERAPY, 2017, 30 (05)
  • [22] Thyroid and lipidic dysfunction associated with bexarotene in cutaneous T-cell lymphoma
    Rodriguez Suarez, Santiago
    Pamies Andreu, Encarnacion
    Muniz Grijalvo, Ovidio
    Garcia Morillo, Jose Salvador
    MEDICINA CLINICA, 2016, 146 (03): : 117 - 120
  • [23] Transcriptome adaptation caused by vorinostat/bexarotene combination therapy in advanced cutaneous T-cell lymphoma
    Karpova, M. B.
    Gunz, D.
    Okoniewski, M. J.
    Cozzio, A.
    Schad, K.
    Conzett, K. Baumann
    Dummer, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Response rates in photopheresis therapy for cutaneous T-cell lymphoma - Reply
    Duvic, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (02) : 288 - 288
  • [25] Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma
    Sokolowska-Wojdylo, Malgorzata
    Florek, Aleksandra
    Zaucha, Jan Maciej
    Chmielowska, Ewa
    Giza, Agnieszka
    Knopinska-Posluszny, Wanda
    Kulikowski, Waldemar
    Prejzner, Witold
    Romejko-Jarosinska, Joanna
    Paszkiewicz-Kozik, Ewa
    Osowiecki, Michal
    Walewski, Jan
    Rogowski, Wojciech
    Grzanka, Aleksandra
    Placek, Waldemar
    Lugowska-Umer, Hanna
    Kowalczyk, Anna
    Nowicki, Roman
    Jurczak, Wojciech
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (03) : e749 - e756
  • [26] Alternative splicing events during vorinostat/bexarotene combination therapy in advanced cutaneous T-cell lymphoma
    Karpova, M. B.
    Okoniewski, M. J.
    Storz-Schweizer, M.
    Gunz, D.
    Cozzio, A.
    Schad, K.
    Baumann-Conzett, K.
    French, L. E.
    Dummer, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 15 - 15
  • [27] Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis
    Demierre, Marie-France
    Ferzli, Pascal
    Miller, Donald
    ARCHIVES OF DERMATOLOGY, 2007, 143 (05) : 659 - 661
  • [28] The role of alternative splicing in the response to vorinostat/bexarotene combination therapy in advanced cutaneous T-cell lymphoma
    Karpova, Maria
    Storz-Schweizer, Martina
    Okoniewski, Michal
    Gunz, Daniela
    Cozzio, Antonio
    Schad, Karin
    Baumann-Conzett, Katrin
    French, Lars
    Fadeel, Bengt
    Dummer, Reinhard
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S45 - S45
  • [29] Evolution of Clinical and Molecular Responses to Bexarotene Treatment in Cutaneous T-Cell Lymphoma
    Ballanger, F.
    Nguyen, J. M.
    Khammari, A.
    Dreno, B.
    DERMATOLOGY, 2010, 220 (04) : 370 - 375
  • [30] Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: A case series
    Singh, F
    Lebwohl, MG
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (04) : 570 - 573
12345